Background: Amyloidosis of the endometrium is a rare occurrence according to current literature. Previously reported cases have presented with menorrhagia or postmenopausal bleeding.
Case: A postmenopausal woman with multiple medical problems presented with fatigue and weight loss. During the evaluation for her 18-kg weight loss, a computed tomography scan revealed an enlarged uterus and liver lesions. Endometrial and liver biopsies were performed secondary to concern over metastatic cancer, given an enlarged uterus in a postmenopausal woman with liver masses. She was found to have systemic primary amyloidosis in multiple organs, including her endometrium.
Conclusion: This patient represents an interesting case of systemic amyloidosis involving the endometrium that is not associated with vaginal bleeding. The presence of amyloid in the endometrium may be more common than currently recognized, because patients without vaginal bleeding are not routinely evaluated for amyloid deposition in their reproductive organs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.AOG.0000124985.48138.7e | DOI Listing |
J Biol Chem
June 2019
From the Instituto Nacional de Câncer, Coordenação de Pesquisa, Programa de Oncobiologia Celular e Molecular, Rio de Janeiro, Brazil,
Dysfunctional p53 formation and activity can result from aberrant expression and subcellular localization of distinct p53 isoforms or aggregates. Endometrial carcinoma (EC) is a cancer type in which p53 status is correlated with prognosis, and mutations are a frequent genetic modification. Here we aimed to evaluate the expression patterns of different p53 isoforms and their contributions to the formation and subcellular localization of p53 amyloid aggregates in both EC and endometrial nontumor cell lines.
View Article and Find Full Text PDFFASEB J
March 2015
Departments of *Pathology, Neuroscience, and Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA; Departments of Pathology, Immunology and Microbiology and Population Health & Reproduction, and California Animal Health and Food Safety Laboratory System, University of California, Davis, Davis, California, USA; and INRA, UMR1313 Unité Génétique Animale et Biologie Intégrative, Jouy-en-Josas, France
Pathologic amyloid accumulates in the CNS or in peripheral organs, yet the mechanism underlying the targeting of systemic amyloid deposits is unclear. Serum amyloid A (SAA) 1 and 2 are produced predominantly by the liver and form amyloid most commonly in the spleen, liver, and kidney. In contrast, SAA3 is produced primarily extrahepatically and has no causal link to amyloid formation.
View Article and Find Full Text PDFArch Gynecol Obstet
October 2007
Department of Pathology, University College of Medical Sciences, Delhi, India.
Background: Amyloidosis is associated with infections, chronic disorders, hematological malignancies and endocrine neoplasms. Only rarely has it been associated with other tumors. Amyloidosis of the endometrium is rare and has only been reported as part of a systemic disease.
View Article and Find Full Text PDFObstet Gynecol
November 2004
Department of Obstetrics and Gynecology, University of South Carolina and Palmetto Richland Memorial Hospital, Columbia, South Carolina, USA.
Background: Amyloidosis of the endometrium is a rare occurrence according to current literature. Previously reported cases have presented with menorrhagia or postmenopausal bleeding.
Case: A postmenopausal woman with multiple medical problems presented with fatigue and weight loss.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!